logo

Paratek Pharmaceuticals, Inc. (PRTK)



Trade PRTK now with
  Date
  Headline
5/16/2018 10:21:00 AM Wedbush Is Lowering Paratek Pharmaceuticals, Inc. (PRTK) Q2 18 Estimate To -0.90 From -0.89
11/17/2017 6:41:27 PM Wedbush Is Increasing Paratek Pharmaceuticals, Inc. (PRTK) FY17 Estimate To -2.51 From -2.96
11/17/2017 6:41:00 PM Wedbush Is Raising Paratek Pharmaceuticals, Inc. (PRTK) Q4 18 Estimate To -0.63 From -0.73
11/17/2017 6:40:45 PM Wedbush Is Raising Paratek Pharmaceuticals, Inc. (PRTK) Q3 18 Estimate To -0.36 From -0.48
11/17/2017 6:40:31 PM Wedbush Is Raising Paratek Pharmaceuticals, Inc. (PRTK) Q2 18 Estimate To -0.77 From -0.89
11/17/2017 6:40:17 PM Wedbush Is Increasing Paratek Pharmaceuticals, Inc. (PRTK) Q1 18 Estimate To -0.75 From -0.86
11/17/2017 6:39:45 PM Wedbush Is Increasing Paratek Pharmaceuticals, Inc. (PRTK) FY17 Estimate To -3.13 From -3.34
11/17/2017 6:39:27 PM Wedbush Is Increasing Paratek Pharmaceuticals, Inc. (PRTK) Q4 17 Estimate To -0.56 From -0.67
4/4/2017 6:35:20 AM Wedbush Reiterates Paratek Pharmaceuticals, Inc. (PRTK) At Ourperform With $34 Up $30 Price Target
4/3/2017 4:18:13 PM Wedbush Initiates Paratek Pharmaceuticals, Inc. (PRTK) At Outperform With $30 Price Target